Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Novavax 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
749
Employees749
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
749
Employees749

NVAX Key Statistics

Market cap
1.41B
Market cap1.41B
Price-Earnings ratio
-14.42
Price-Earnings ratio-14.42
Dividend yield
Dividend yield
Average volume
6.19M
Average volume6.19M
High today
$9.72
High today$9.72
Low today
$8.60
Low today$8.60
Open price
$9.57
Open price$9.57
Volume
6.86M
Volume6.86M
52 Week high
$11.97
52 Week high$11.97
52 Week low
$6.13
52 Week low$6.13

Stock Snapshot

Novavax(NVAX) stock is priced at $8.72, giving the company a market capitalization of 1.41B. It carries a P/E multiple of -14.42.

On 2026-06-08, Novavax(NVAX) stock traded between a low of $8.60 and a high of $9.72. Shares are currently priced at $8.72, which is +1.4% above the low and -10.3% below the high.

Novavax(NVAX) shares are trading with a volume of 6.86M, against a daily average of 6.19M.

In the last year, Novavax(NVAX) shares hit a 52-week high of $11.97 and a 52-week low of $6.13.

In the last year, Novavax(NVAX) shares hit a 52-week high of $11.97 and a 52-week low of $6.13.

NVAX News

MarketWatch 3d
Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch

...

Novavax Inc. stock underperforms Friday when compared to competitors - MarketWatch
TipRanks 3d
Novavax’s Combo COVID-19 and Flu Shot Trial Reaches Key Milestone for Older Adults

Novavax (NVAX) announced an update on their ongoing clinical study. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and...

Simply Wall St 6d
Assessing Novavax Valuation After Recent Share Price Strength And Ongoing Vaccine Commercialization

Advertisement Recent performance snapshot Novavax (NVAX) has drawn fresh attention after a period where the stock rose around 31% over the past month and abou...

Assessing Novavax Valuation After Recent Share Price Strength And Ongoing Vaccine Commercialization

Analyst ratings

56%

of 9 ratings
Buy
55.6%
Hold
11.1%
Sell
33.3%

People also own

Based on the portfolios of people who own NVAX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.